HomeDrugsInstructions for Drug, Cosmetic, and Medical Device Sampling by Drugs Inspectors Under Central and State Drug Agencies as of 9th February, 2024 Instructions for Drug, Cosmetic, and Medical Device Sampling by Drugs Inspectors Under Central and State Drug Agencies as of 9th February, 2024Drugs, FDA / December 2, 2024 Instructions for the sampling procedures of pharmaceuticals, cosmetics, and medical devices by Drugs Inspectors from both Central and State Drug Agencies dated 9th February, 2024
China NMPA Grants Priority Review for Ascentage Pharma’s Lisaftoclax, a Novel Bcl-2 Inhibitor for r/r CLL/SLL Drugs, FDA
